(MedPage Today) — BERLIN — Non-small cell lung cancer (NSCLC) patients starting immunotherapy were nearly twice as likely to be alive 3 years later if they got a COVID-19 vaccine around the time of treatment, a researcher reported here.
Retrospective…
Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118051
Author :
Publish date : 2025-10-20 21:37:00
Copyright for syndicated content belongs to the linked Source.
